Aging, dementia and calcium metabolism

Journal of Neural Transmission, Supplement

Volumn , Issue 54, 1998, Pages 195-200

  Kanowski, S ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NIMODIPINE; PIRACETAM; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT;

AGING; ALZHEIMER DISEASE; CALCIUM HOMEOSTASIS; CALCIUM METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MAJOR CLINICAL STUDY; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; AGED; ANIMAL; BRAIN; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGED; AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; CALCIUM; CALCIUM CHANNEL BLOCKERS; DEMENTIA, VASCULAR; HUMANS; NIMODIPINE;

EID: 0031593609     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-7508-8_19     Document Type: Review

References (12)

1. + channels. Science 264: 276-279
2. Fischhof P, Wagner G, Littschauer, et al (1989) Therapeutic results with nimodipine in primary degenerative dementia and multi-infarct dementia. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York Tokyo, pp 350-359
3. Grobe-Einsler R (1993) Clinical aspects of nimodipine. Clin Neuropharmacol 16 [Suppl 1]: 39-45
4. Hartmann H, Eckert A, Velbinger K, et al (1996) Down-regulation of free intracellular calcium in dissociated brain cells of aged mice and rats. Life Sci 59: 435-449
5. Kanowski S, Fischhof P, Hiersemenzel R, et al (1988) Wirksamkeitsnachweis von Nootropika am Beispiel von Nimodipin - ein Beitrag zur Entwicklung geeigneter klinischer Prüfmodelle. Z Gerontopsychol psychiatr 1: 35-44
6. Kanowski S, Fischhof P, Hiersemenzel R, et al (1989) Therapeutic efficacy of nootropic drugs - A discussion of clinical phase III studies with nimodipine as a model. In: Bergener M, Reisberg B (eds) Diagnosis and treatment of senile dementia. Springer, Berlin Heidelberg New York Tokyo, pp 339-349
7. Khachaturian ZS (1989) The role of calcium regulation in brain aging: reexamination of a hypothesis. Aging 1: 17-34
8. Morich FJ, Bieber F, Lewis JM, et al (1996) Nimodipine in the treatment of probable Alzheimer's disease. Results of two multicenter trials. Clin Drug Invest 11: 185-195
9. Müller WE, Eckert A, Hartmann H, et al (1996) Zur Kalziumhypothese der Hirnalterung. Nervenarzt 67: 15-24
10. Schmage N, Dycka J (1991) Auswertung von verschiedenen psychometrischen Verfahren aus klinischen Studien mit Nimodipin. In: Möller H-J (Hrsg) Hirnleistungsstörungen im Alter. Springer, Berlin Heidelberg New York Tokyo, pp 97-104
11. Schmage N, Bergener M (1992) Global rating, symptoms, behaviour and cognitive performance as indicators of efficacy in clinical studies with nimodipine in elderly patients with cognitive impairment syndromes. Int Psychogeratr 4: 89-99
12. Zirm B, Steinwachs KC, Pracher G, et al (1994) Effects of nimodipine and piracetam on speed of information processing (ZVT: G) and clinical dementia symptoms - results of an unicenter randomized clinical trial. Z Gerontopsychol psychiatr 7: 157-168